Nothing Special   »   [go: up one dir, main page]

Mathews, 2020 - Google Patents

The proliferating cell nuclear antigen, PCNA, a cell growth-regulated DNA replication factor

Mathews, 2020

Document ID
11090309323887648219
Author
Mathews M
Publication year
Publication venue
Growth control during cell aging

External Links

Snippet

This chapter employs the term proliferating cell nuclear antigen (PCNA) to denote this protein, mainly on the ground of historical precedence, but also because the name “cyclin” is used for other proteins and reagents, and “DNA polymerase-d auxiliary protein” is a …
Continue reading at www.taylorfrancis.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Mathews The proliferating cell nuclear antigen, PCNA, a cell growth-regulated DNA replication factor
Mcelhinny et al. Casein kinase II phosphorylates IκBα at S-283, S-289, S-293, and T-291 and is required for its degradation
Johnson et al. Cellular transformation and malignancy induced by ras require c-jun
Wolthuis et al. Stimulation of gene induction and cell growth by the Ras effector Rlf
Cacalano et al. Autosomal SCID caused by a point mutation in the N‐terminus of Jak3: mapping of the Jak3–receptor interaction domain
Li et al. A cdc15‐like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2‐triggered adhesion
US5733730A (en) Telomere repeat binding factor and diagnostic and therapeutic use thereof
KR100536394B1 (en) Function modulators of FAS / AP01 receptors
US20220193193A1 (en) Methods for identification, assessment, prevention, and treatment of metabolic disorders using slit2
US5877161A (en) Cyclin D1 negative regulatory activity
AU2005219322B2 (en) Pharmaceutical Composition Comprising CXCR3 Inhibitor
USRE43497E1 (en) Anti-MIF antibodies
US6297356B1 (en) Telomere repeat binding factors and diagnostic and therapeutic use thereof
US20110182811A1 (en) Nucleotide sequence encoding a modulator of nf-kb
EP1687330A1 (en) Peptides with anti-obesity activity and other related uses
US6312941B1 (en) Compositions and methods for identifying signaling pathway agonists and antagonists
AU3926893A (en) Ifn receptors recognition factors, protein sequences and methods of use thereof
JP5286602B2 (en) Insulin resistance improving drug
US7339039B2 (en) Nucleic acids encoding receptor recognition factors, and methods of use thereof
Sakurai et al. In vitro analysis of STAT5 activation by granulocyte‐macrophage colony‐stimulating factor
US20050084916A1 (en) Identification of the IkappaBNS protein and its products
Watson Production and characterisation of monoclonal and polyclonal antibodies against the transcription factor NF-kB and its inhibitor I-kB
US20020164299A1 (en) TNF and IFN stimulated genes and uses therefor
Seshadri Altered gene expression during growth inhibition by interferons and cellular senescence
US20090042233A1 (en) Novel protein member of the ras/mapk pathway, antibodies thereof and methods and kits of using same